🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Biological therapies, such as GM-CSF, may stimulate the immune s...
Status
Unknown
Location
Multiple Locations
Start Date
2009-03
Trial ID
NCT00893477
RATIONALE: Collecting and storing samples of tumor tissue, blood, bone marr...
Status
Unknown
Location
Universitair Ziekenhuis Antwerpen
Start Date
2011-06
Trial ID
NCT01185886
RATIONALE: Studying samples of bone marrow and blood from patients with can...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00897624
RATIONALE: Collecting and storing samples of blood and tumor tissue from pa...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2005-08
Trial ID
NCT00898508
Treatments Being Tested
Monoclonal antibodies, such as pertuzumab and cetuximab, can block tumor gr...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2007-10
Trial ID
NCT00551421
RATIONALE: Studying samples of blood and tissue from patients at risk of ca...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00611000
RATIONALE: Giving chemotherapy, such as clofarabine and melphalan, before a...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2007-07
Trial ID
NCT00641030
RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Status
Completed
Location
Multiple Locations
Start Date
2008-03-15
Trial ID
NCT00900172
RATIONALE: Studying samples of blood and tumor tissue from patients with ca...
Status
Completed
Location
Multiple Locations
Start Date
2010-08-05
Trial ID
NCT01194635